Endocyte, Inc. – NASDAQ:ECYT
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 4 hours
Endocyte key metrics
Market Cap | N/A |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | 128.67K |
EBITDA | -42.78M |
Income | -38.98M |
Revenue Q/Q | 164.16% |
Revenue Y/Y | 83.82% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -33251.16% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEndocyte stock price history
Endocyte stock forecast
Endocyte financial statements
| Dec 2017 | 12.5K | -8.30M | -66437.86% |
|---|---|---|---|
| Mar 2018 | 15.85K | -8.18M | -51654.05% |
| Jun 2018 | 14.46K | -10.84M | -74968.79% |
| Sep 2018 | 85.85K | -11.64M | -13567.57% |
| Dec 2017 | 100762269 | 5.27M | 5.24% |
|---|---|---|---|
| Mar 2018 | 176678230 | 4.97M | 2.82% |
| Jun 2018 | 172168805 | 6.30M | 3.66% |
| Sep 2018 | 355204305 | 8.00M | 2.25% |
| Dec 2017 | -6.24M | -23.37M | 1.00M |
|---|---|---|---|
| Mar 2018 | -7.70M | -4.16M | 83.13M |
| Jun 2018 | -11.05M | -57.97M | 4.23M |
| Sep 2018 | -15.52M | -134.52M | 192.27M |
Endocyte other data
-
When is Endocyte's next earnings date?
Unfortunately, Endocyte's (ECYT) next earnings date is currently unknown.
-
Does Endocyte pay dividends?
No, Endocyte does not pay dividends.
-
What is Endocyte's stock symbol?
Endocyte, Inc. is traded on the NASDAQ under the ticker symbol "ECYT".
-
How do i buy shares of Endocyte?
Shares of Endocyte can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When Endocyte went public?
Endocyte, Inc. is publicly traded company for more then 14 years since IPO on 4 Feb 2011.